landscape in Medical Technology

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

... PhD, Chief Medical and Scientific Officer at the Alzheimer's Association. "Fortunately, the field is progressing and we may soon see changes in the landscape of Alzheimer's diagnosis, care, treatment, and prevention. How fast we get there depends completely on investment in research. We must capitalize on ...

More Gene Mutations Linked to Autism Risk

... individuals in families. The findings were published in the June 26 edition of the journal PloS Genetics . By further refining the genetic landscape of ASDs, the current study expands the findings of two large autism gene studies published in April, led by Hakonarson and co-authored by Gerard ...

Gene Findings Unlocking Reasons for Neuroblastoma Risk

... led to a clinical trial led by Dr. Yael Mosse of The Children's Hospital of Philadelphia. As gene studies continue to better define the genetic landscape of neuroblastoma, added Maris, pediatric oncologists can better develop more precise targeted treatments to improve survival and quality of life for ...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

... began to receive payments for the licensing. OTC success With the establishment of the OTC, Rensselaer has staked its claim in the changing landscape of American research universities, where researchers are increasingly encouraged to protect their discoveries and hopefully effectively license them ...

Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial

... said: "We are delighted that Bronchitol performed so well in this important long term study and we now know that it can change the therapeutic landscape for many of the 75,000 people with this disease. In a trial which recruited a wide range of patients with varying disease severity, Bronchitol showed ...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

... Center for Global Health at Cincinnati Children's Hospital, will present the conference's Robert Austrian Memorial Lecture titled, The Ever Changing landscape of Pneumococcal Sero-Type Epidemiology, at 11:30 a.m. Tuesday. The lecture, which is underwritten by a grant from Merck & Co., Inc., honors the ...

Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis

... major milestone for Pharmaxis and look forward to the results of the study with great interest. It is hoped Bronchitol will change the therapeutic landscape for people living with cystic fibrosis and provide a new therapeutic regimen that helps to prolong life." The second component of the trial ...

New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option

... of translating PrEP and other HIV prevention research into effective policy and practice. "PrEP trials are taking place within a changing landscape of HIV prevention research," said AVAC Executive Director Mitchell Warren. "Disappointing results have emerged from recent studies of vaccine ...

New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition

... young. But it is revolutionary therapies like this one that are giving neurointerventional practitioners the opportunity to change the entire landscape of patient care." About SNIS SNIS members are neurointerventional practitioners with backgrounds in neuroradiology, neurosurgery and neurology ...

Pew Commission Says Industrial Scale Farm Animal Production Poses 'Unacceptable' Risks to Public Health, Environment

... from the tremendous quantities of animal waste that are concentrated on IFAP premises. Animal waste in such volumes may exceed the capacity of the landscape to absorb the nutrients and neutralize pathogens. Thus, what should be a valuable byproduct (e.g., fertilizer) becomes a waste that must be disposed ...

Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin

... The Company remains confident in its regulatory strategy for cethromycin in the CAP indication. To gain further insight into the evolving regulatory landscape for antibiotic drug development, members of the management and scientific teams will be present at the upcoming FDA Anti-Infectives Advisory ...

Industry Executives Finding Value in Shift of Scientific Publications

... CHAPEL HILL, N.C., Feb. 15 /PRNewswire/ -- The landscape of scientific publications strategy, planning and delivery is changing with the advent of transparency guidelines. Half of global publications groups ...

Physicians Will Benefit from Medical Software Advice Website

... medical software buyers with the right technology for their practices. "The market for medical software is booming, but the software vendor landscape is more fragmented than ever," said Don Fornes, founder & Chief Executive Officer of Software Advice. "We aim to bring clarity to the ...

Medifast, Inc. Announces Acceptance for Publication of Clinical Efficacy Study

... pounds per week. While the Company does not recommend the use of weight loss drugs, Medifast does recognize that diet pills are very much part of the landscape now and in the future. Medifast is a proven program that can ensure consumers are successful on drug therapy regimens that include a reduced calorie ...

Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials

... skills, and ability and willingness to confront and resolve tough issues will be extremely valuable to FMS as we continue to grow and change the landscape of health care." About Flexible Medical Systems Flexible Medical Systems, LLC (FMS) is a privately held medical device and diagnostic company ...

Syndicom SpineConnect Web Platform Chosen for Applied Spine's Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System

... provide stabilization of the lumbar spine in patients receiving decompression surgery for the treatment of spinal stenosis. "Today's clinical trial landscape is littered with trials that fail to meet their planned timelines and patient accrual goals," said Thomas E. Wood, CEO of Applied Spine. "What has ...

Hospitalization Rates for Coronary Artery Disease Decline in the U.S.

... of Michigan Medical School and health services researcher at the Ann Arbor Veterans Administration Medical Center. "There is reason to believe this landscape will continue to change. Recent research, for example, raises questions about the use of drugs, stents, and surgery under various scenarios. Clearly, ...

Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific Anticalin in Preclinical Studies

... Pieris and its collaborators are not only able to develop superior biotherapeutics, but they also have the ability to overcome the encumbering patent landscape as currently present for developing conventional antibodies. About VEGF and PRS-050 Angiogenesis - the development of new blood vessels ...

Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer

... R. Allen, chief medical officer of Pharmion. "We are encouraged by these initial results which suggest Amrubicin's potential to improve the treatment landscape for small cell lung cancer." The trial compares Amrubicin and topotecan in patients with ED-SCLC that initially responded to first-line ...

Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors

... our intellectual property and operate our business without infringing upon the intellectual property rights of others, changes in the competitive landscape including changes in the standard of care for the various indications in which MethylGene is involved, and changes to the competitive environment due ...

Ivivi's PEMF Technology Significantly Improves Neuron Survival in Parkinson's Disease Model, Study Finds

... the Company's intellectual property, the loss of any executive officers or key personnel or consultants, competition, changes in the regulatory landscape or the imposition of regulations that affect the Company's products and other risks detailed from time to time in the Company's filings with ...

Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology

... Pieris and its collaborators are not only able to develop superior biotherapeutics, but they also have the ability to overcome the encumbering patent landscape as currently present for the development of conventional antibodies. About the Duocalin(R) technology Pieris can format Anticalin leads as dual ...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

... research & development at Johnson & Johnson Pharmaceutical Research and Development commented: "We believe rivaroxaban could alter the landscape of antithrombotic therapy. An effective once-daily oral anticoagulant that can be administered safely and conveniently in the hospital and ...